AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Financial Summary DOVA Quote Dova Pharma

Dova Pharmaceuticals Inc. Quote

Dova Pharmaceut (DOVA)

7.50 -0.59 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol DOVA
Price 7.50
Beta 1.01
Vol Avg 176.23 K
Mkt cap 753.17 M
Shares 21
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -98.36% Strong Sell
ROA -62.50% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 57.38% Buy
P/E -5.25 Strong Sell
P/B 2.58 Strong Buy
Company Profile

CEO

Alex Sapir

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

Dova Pharmaceuticals Inc is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia.